Show simple item record

dc.contributor.authorTjelta, Johannes
dc.contributor.authorFjæra, Lars Fredrik
dc.contributor.authorYtre-Hauge, Kristian Smeland
dc.contributor.authorBoer, Camilla Grindeland
dc.contributor.authorStokkevåg, Camilla Hanquist
dc.date.accessioned2024-05-03T10:55:32Z
dc.date.available2024-05-03T10:55:32Z
dc.date.created2023-11-29T13:00:24Z
dc.date.issued2023
dc.identifier.issn0031-9155
dc.identifier.urihttps://hdl.handle.net/11250/3129006
dc.description.abstractObjective. While integration of variable relative biological effectiveness (RBE) has not reached full clinical implementation, the importance of having the ability to recalculate proton treatment plans in a flexible, dedicated Monte Carlo (MC) code cannot be understated . Here we provide a step-wise method for calibrating dose from a MC code to a treatment planning system (TPS), to obtain required parameters for calculating linear energy transfer (LET), variable RBE and in general enabling clinical realistic research studies beyond the capabilities of a TPS. Approach. Initially, Pristine Bragg peaks (PBP) were calculated in both the Eclipse TPS and the FLUKA MC code. A rearranged Bortfeld energy-range relation was applied to the initial energy of the beam to fine-tune the range of the MC code at 80% dose level distal to the PBP. The energy spread was adapted by dividing the TPS range by the MC range for dose level 80%–20% distal to the PBP. Density and relative proton stopping power were adjusted by comparing the TPS and MC for different Hounsfield units. To find the relationship of dose per primary particle from the MC to dose per monitor unit in the TPS, integration was applied to the area of the Bragg curve. The calibration was validated for spread-out Bragg peaks (SOBP) in water and patient treatment plans. Following the validation, variable RBE were calculated using established models. Main results. The PBPs ranges were within ±0.3 mm threshold, and a maximum of 5.5% difference for the SOBPs was observed. The patient validation showed excellent dose agreement between the TPS and MC, with the greatest differences for the lung tumor patient. Significance. A procedure for calibrating a MC code to a TPS was developed and validated. The procedure enables MC-based calculation of dose, LET, variable RBE, advanced (secondary) particle tracking and more from treatment plans.en_US
dc.language.isoengen_US
dc.publisherIOPen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleA systematic approach for calibrating a Monte Carlo code to a treatment planning system for obtaining dose, LET, variable proton RBE and out-of-field doseen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2023 The Author(s)en_US
dc.source.articlenumber225010en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.1088/1361-6560/ad0281
dc.identifier.cristin2205190
dc.source.journalPhysics in Medicine and Biologyen_US
dc.identifier.citationPhysics in Medicine and Biology. 2023, 68 (22), 225010.en_US
dc.source.volume68en_US
dc.source.issue22en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal